Skip to main content
Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc. — Investor Relations & Filings

Ticker · VERA ISIN · US92337R1014 US Professional, scientific and technical activities
Open in API
Filings indexed 418 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country US United States of America
Listing US VERA

About Vera Therapeutics, Inc.

https://veratx.com/

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological and rare diseases. The company's mission is to change the standard of care and improve patients' lives. Its lead product candidate is atacicept, a novel biologic molecule being developed for the treatment of IgA nephropathy (IgAN), a progressive autoimmune kidney disease. Vera Therapeutics aims to advance its pipeline of innovative therapies to address significant unmet medical needs within immunology.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 90% confidence The document is a Form 8-K “Current Report” filed under Section 13 or 15(d) of the Securities Exchange Act of 1934. It reports an “Other Event” – a press release on FDA alignment and clinical plan updates – and includes forward‐looking statements and signature. It is not a full financial report (10‐K or quarterly), nor earnings release, nor investor presentation, but a regulatory disclosure form. According to the taxonomy, generic SEC current reports (8‐K) are categorized under Regulatory Filings (RNS).
2026-06-02 English
8-K
Regulatory Filings
2026-05-26 English
8-K - Vera Therapeutics, Inc. (0001831828) (Filer)
Regulatory Filings Classification · 90% confidence The document is a Form 8-K “Current Report” filed with the SEC under Section 13 or 15(d). It furnishes a press release of first quarter results as Exhibit 99.1, but the text provided is the 8-K itself, not the underlying press release or a full earnings release. There is no substantive financial data beyond referencing the press release. Under the taxonomy, generic SEC filings that do not fit another specific category are classified as Regulatory Filings (RNS).
2026-05-07 English
ARS - Vera Therapeutics, Inc. (0001831828) (Filer)
Annual Report
2026-04-09 English
DEF 14A - Vera Therapeutics, Inc. (0001831828) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English
4 - Vera Therapeutics, Inc. (0001831828) (Issuer)
Director's Dealing
2026-03-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.